China Pharmaceutical Regulatory Report 2011, the research report that gives you a thorough understanding of the Chinese regulatory structure governing the drug industry. You’ll get a complete discussion of the laws and regulations that govern the testing, product registration, manufacturing, importing, marketing and sales of pharmaceuticals. Specific topics include:

• Drug classification
• Product registration
• Pricing and reimbursement
• Importation
• Good manufacturing practices
• Intellectual property protection

Drug pricing, applicable World Trade Organization agreements, distribution rules and OTC sales — they’re all covered here, along with the good clinical and good laboratory practice regulations you need to understand to get your product approved. All this and more from Ames Gross of Pacific Bridge Medical, the consulting firm that has provided hundreds of companies with regulatory information and business strategies to develop Asian markets.

China Pharmaceutical Regulatory Report 2011, your one-stop guide to doing business in this growing market, includes a full translation of the revised Administrative Provisions for Drug Registration — updated for 2011. In addition, you’ll get translations of:

• Key pharmaceutical regulations
• Pharmaceutical statistics
• Registration forms
• Contacts for China contract research organizations
• A timeline for the pharmaceutical registration process

Click here to view a sample page of this report.

Buy Now!
Make sure you’re up to speed with the latest regulations in the world’s most populous nation with China Pharmaceutical Regulatory Report 2011. Priced at $1,600 (including shipping) and available to you today.

Need your copy in a rush? You may receive your order express delivery for an additional $50. International express delivery takes two days. In the U.S., your order will be shipped for overnight delivery.

Your purchase is nonrefundable. All sales are final.